HC Wainwright & Co. Maintains Buy on VolitionRX, Lowers Price Target to $1

Benzinga Newsdesk www.benzinga.com Neutral 55.5%

Neg 0% Neu 55.5% Pos 0%

HC Wainwright & Co. analyst Yi Chen maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $1.5 to $1.